1. Evidence for actuarial senescence (i.e. the decrease in survival with increasing age) is now widespread across the tree of life. However, demographic senescence patterns are highly variable both between and within species. To understand these variations, there is an urgent need to go beyond aggregated mortality rates and to investigate how age-specific causes of mortality in animals interact with agespecific physiological performance. We address this question in the context of cancers.
| THE PROB LEMATI C S OF S ENE SCEN CE AND C AN CER
The last decades have seen a burst in the number of studies providing evidence for a decrease in survival and reproductive success with increasing age (processes coined actuarial and reproductive senescence, respectively) in both wild and captive populations of animals (Jones et al., 2014; Nussey, Froy, Lemaître, Gaillard, & Austad, 2013) .
Such declines in age-specific life-history traits are supposed to be underlined by a progressive deterioration of organism along the life course (henceforth coined 'senescence'), generally described in free-ranging populations through a loss of body mass (e.g. Douhard, Gaillard, Pellerin, Jacob, & Lemaître, 2017) or physiological performance (e.g. immune performance, Ujvari & Madsen, 2011) . While the demographic senescence process appears pervasive across species, the complex interplay between the deterioration of physiological functions and body condition and the concomitant increase in susceptibility to diseases culminating in death is yet to be deciphered.
The 'emperor of all maladies', cancer, illustrates this complexity.
Cancer is a leading cause of death worldwide in humans (Bray et al., 2018) , and albeit the extensive investment into molecular and cellular research focusing on the mechanisms of carcinogenesis, whether senescence and cancer development share similar evolutionary pathways remains to be determined (De Magalhães, 2013) . Currently, the lack of congruence between mechanistic and eco-evolutionary models linking age-specific deterioration of physiological functions and cancer hinders our understanding of the role of cancer in actuarial and reproductive senescence. In addition, the limited information available on cancer incidence in relation to age in wild populations (Albuquerque, Drummond do Val, Doherty, & Magalhães, 2018; Madsen et al., 2017) hinders any empirical assessment of the functional relationship linking demographic senescence and carcinogenesis. While cancer is ubiquitous in multicellular organisms , we are not yet able to predict a species' cancer prevalence with respect to its phylogenetic history, ecology, physiology, lifestyle and biodemographic strategy . In fact, based on limited data, cancer prevalence and age-specific incidence appear not to lie in any of the known ecological continua structuring the diversity of life-history strategies (e.g. slow-fast continuum, Gaillard et al., 2016) , nor fitting the dominant mechanistic molecular and cellular model of carcinogenesis (see Box 1).
Cancer originates from the (epi)genetic alterations of a given cell. The dominant theory (also referred to as the 'Doll-Armitage multistage', Armitage & Doll, 1954) is that carcinogenesis is a multistage process of accumulation of (epi)mutations in a mitotic cell lineage that liberates a cell from homeostatic mechanisms of cell division, often due to inhibited attrition of telomeres. Although it has recently been argued that lifetime risk of cancer correlates with the total number of cell divisions in a given tissue (Tomasetti, Li, & Vogelstein, 2017; Tomasetti & Vogelstein, 2015) , the kinetics of damage accumulation with age and its consequences on the age-specific patterns of cancer prevalence and incidence remain largely unknown (Rozhok & DeGregori, 2015) . Furthermore, these proximate factors of carcinogenesis (i.e. (epi)genetic instability and telomere attrition) also belong to the 'primary hallmarks' of ageing by being involved in the progressive deterioration of various biological functions (López-Otín, Blasco, Partridge, Serrano, & Kroemer, 2013) . Variations in cancer prevalence between and within species should thus be mainly determined by differential somatic mutation rate and repair efficiency. As the immediate results of the proximal deteriorations occurring with age, both processes of carcinogenesis and senescence should be tightly linked. However, understanding the causality of the relationship linking cancer and senescence (at cellular, individual and population levels) and deciphering their complexity through the lenses of evolutionary biology is particularly arduous (Hofman et al., 2019) . In that context, several hypotheses have recently emerged. The aim of this article is thus to provide a critical reappraisal of these new hypotheses and to identify salient research directions that evolutionary ecologists should embrace.
Once a cancer cell is generated (even by a multistage process), cancer cell proliferation is then mediated by both the immune response and the competition between cancer and normal cell lineages. It has thus been recently argued that cancer incidence and prevalence are mostly shaped by defence mechanisms preventing tumour cells to transform into invasive cancer (Harris, Schiffman, & Boddy, 2017) . Immunosenescence (i.e. the decline in immune function with increasing age) can therefore lead to increased cancer incidence due to decreasing efficiency in cancer cells' predation and senescence and cancer patterns, which emphasize the tight and complex relationships linking these processes.
5.
We propose a conceptual background to lay down the foundations and the directions of future research projects aiming to disentangle the dynamic relationship between the evolution of cancer and senescence. We argue that studies embracing these research directions will markedly improve our understanding of both cancer prevalence and timing at the individual, population and species level. increased inflammation with age. In addition, the senescence process might induce a change in the cells' adaptive landscape making healthy cells less competitive compared to cancer cells (Liggett & DeGregori, 2017) . If true, mortality and cancer incidence should exhibit a similar pattern with age. However, while the current prevailing paradigm posits that all physiological functions should senesce at the same pace (Maynard Smith, 1962; Williams, 1957) , recent studies have demonstrated that this may not be true , which could potentially explain differences in the shape of cancer incidence and age-specific mortality by other causes. To evaluate these different hypotheses, it is mandatory to first determine whether individual-based mechanistic theory of carcinogenesis can be embedded within a population-based evolutionary theory of senescence.
| DOE S C AN CER MED IATE THE REPRODUC TI ON -S ENE SCEN CE TR ADE-OFF ?
The predominant hypothesis related to the evolution of senescence is based on an evolutionary trade-off between reproduction and subsequent mortality. This trade-off takes its origin in the 'antagonistic pleiotropy theory' of ageing (Williams, 1957) . Based on the assumption that the force of natural selection against fitness impairing genes decreases with age (Hamilton, 1966; Medawar, 1952) , George C. Williams proposed that allele(s) can be selected by natural selection trough a positive effect on reproductive success during early life even if such allele(s) is responsible for increased senescence in late life. While detecting such alleles is challenging, experimental manipulations in laboratory models and quantitative genetic approaches performed on wild populations of animals have provided support to this theory (see for a review). The key role of reproductive allocation in shaping reproductive and actuarial senescence patterns was then emphasized in the 'disposable soma theory' of ageing (see Kirkwood, 2017 for a comprehensive review), a theory originally focusing on the maintenance of molecular and cellular integrity (Kirkwood, 1977) . In its current form, the disposable soma theory adopts assumptions and predictions that are common with life-history theory as they both give a pivotal role to the principle of allocation (Cody, 1966) , namely that individuals need to share a finite pool of resources extracted from the environment between different functions like growth, reproduction and survival (Kirkwood & Rose, 1991; Stearns, 1992) . However, the disposable soma theory explicitly involves the concept of 'somatic maintenance' (Holliday, 1995) based on evidence that organisms have evolved dedicated but costly mechanisms (e.g. enzymatic complexes) that insure the fidelity of DNA replication and repair, as well as the accuracy of protein synthesis (Gladyshev, 2016) . Therefore, resources devoted to growth and reproduction cannot be simultaneously used BOX 1 The paradox of cancer prevalence and age-specific incidence across the tree of life Peto's paradox: Multistage carcinogenesis predicts that a species' cancer prevalence should be a function of the number of cell divisions (then of species size) per unit of time (then of life span). As first noted by Sir Richard Peto (Peto, Roe, Lee, Levy, & Clack, 1975) , this prediction seems not to be supported when comparing mice and humans. Mice are about 1,000 times smaller and about 30 times shorter lived than humans but cancer incidence is about the same in the two species. This led Peto to ask whether our stem cells are 'a billion or a trillion times more 'cancer-proof' than murine stem cells?' and 'Why don't we all die of multiple carcinoma at an early age?' (Peto, 1976 (Peto, , pp 1413 (Peto, -1414 . Scarcity of data and more specifically age-specific data yet prevent to properly test whether Peto's paradox holds across taxa (but see Abegglen et al., 2015) . Indeed, while multistage carcinogenesis theory predicts a positive correlation between cancer prevalence and life span, cancer morbidity is by contrast obviously negatively correlated to life span, an effect never properly accounted for. So far the best hypothesis that accommodates for both the multistage theory and also solves Peto's paradox is the existence of better cancer suppression in larger species compared to small ones (Abegglen et al., 2015 ; but see Caulin, Graham, Wang, & Maley, 2015) . For instance, bowhead whale (Balaena mysticetus) carry specific genes involved in DNA repair and cell-cycle regulation that potentially confer advantages against cancers (Keane et al., 2015) , which is in line with repeated evidence that long-lived species
show more efficient DNA repair mechanisms (Freitas & de Magalhães, 2011) . However, many alternative but so far untested hypotheses have also been proposed (see Nunney, Maley, Breen, Hochberg, & Schiffman, 2015 for a synthesis).
The paradox of deceleration and decline of cancer incidence with age. Multistage carcinogenesis indeed predicts that cancer incidence with age should closely match in shape the increase of mortality with age. However, this is not the case in humans: after a phase of increase, the cancer incidence curve decelerates and even declines in very old ages (Smith, 1996) . As a consequence, the proportion of death by cancer decreases after age 60-70, making cancer less responsible for actuarial senescence and eventually cancer becomes one of the least prevalent causes of death in centenarians (Nolen et al., 2017) . This has long been explained by population biases, as the selective disappearance with age of individuals genetically/environmentally more susceptible to cancer (Vaupel & Yashin, 1999) . However, such deceleration has also been observed in domestic dog breeds (Fleming, Creevy, & Promislow, 2011) and homogenic rats under controlled environment (Anisimov, Ukraintseva, & Yashin, 2005) , leading researchers to argue that this paradox may have some physiological grounds. Here again, its generality across species need to be assessed.
for somatic maintenance, which might compromise cellular integrity and, on the long-run, be responsible for a premature and/or accelerated reproductive and actuarial senescence (Kirkwood, 2017; Kirkwood & Rose, 1991) .
Both the antagonistic pleiotropy and the disposable soma theories of ageing (Kirkwood & Rose, 1991; Williams, 1957) jointly predict a negative relationship between reproductive effort in early life and fitness-related traits in late life. This prediction has been so far broadly validated through the use of genetic and phenotypic data and across a wide range of organisms (Lemaître et al., 2015) . As the occurrence of cancers impairs survival prospects, whether the development of tumour can be embedded in such early-versus late life trade-off deserves some attention . While At the genetic level, a few alleles involved in carcinogenesis but conferring advantages in terms of reproductive success have been identified (i.e. Inherited Cancer Mutant Alleles, see Arnal et al., 2016 for a review). Among them, the Xmrk melanoma-promoting oncogene found in fish from the genus Xiphophorus constitutes an iconic example. In Xiphophorus cortezi, the presence of melanoma on the male caudal fin exacerbates the spotted caudal melanin pattern, which ultimately increases female preference during mate choice experiments, even if it shortens the duration of reproductive life span (Fernandez & Morris, 2008) . Although this example suggests that cancer might mediate the genetic trade-off between reproduction and survival predicted by the antagonistic pleiotropy of ageing, it is important to notice that such clear-cut examples remain rare, sometimes equivocal, and mostly limited to human and laboratory models (e.g. BRCA1/2 mutations, see Smith, Hanson, Mineau, & Buys, 2012) .
In non-model organisms, fine-scale genetic data are generally unavailable and most supports for early-versus late life trade-offs rely on covariation patterns between life-history traits depicting reproductive effort and life span and/or senescence measurements (Lemaître et al., 2015) . Interestingly, reproductive effort has also been associated with the risk of developing cancer in wild populations of animals . For instance, in Tasmanian devils (Sarcophilus harrisii), female fecundity rates were positively associated with the risk of contracting facial tumours (the Tasmanian devil facial tumour disease, DFTD, one of the very rare example of transmissible cancer) during their lifetime (Wells et al., 2017) , and males that are the most aggressive during intersexual competition suffer from a stronger risk of contracting the disease through bites Figure 1 ). Although the relative importance of facial tumour occurrence in terms of actuarial and reproductive senescence (e.g. Russell et al., 2018) has not yet been quantified, the stronger decline in body condition in affected male Tasmanian devils compared to affected females suggests that this cancer influences sex differences in life span and actuarial senescence patterns (Ruiz-Aravena et al., 2018) .
A higher risk of carcinogenesis when the level of intraspecific competition is high has been theoretically investigated by Boddy, Kokko, Breden, Wilkinson, and Aktipis (2015) in a model where competitiveness is a declining function of allocation into cancer defences. This model predicts that cancer should be more prevalent in males than in females (as observed in humans, see Clocchiatti, Cora, Zhang, & Dotto, 2016) . As the increased cell proliferation associated with the rapid growth of body size or secondary sexual traits can also increase cancer susceptibility (De Magalhães, 2013), males who grow faster and also develop and maintain conspicuous sexual traits might be at higher risk of cancers, especially malignancies of the reproductive system (e.g. testes cancer, antleromas). This also suggests that, in such species, cancer might potentially trigger male reproductive senescence rather than actuarial senescence, and potentially contributes to the observed uncoupling between these two processes . Taken together, these predictions from theoretical approaches combined F I G U R E 1 The life-history origins of carcinogenesis. An individual's allocation to growth and reproduction can increase cancer risk through multiple pathways. The relationship can sometimes be direct if, for example, higher rates of antagonistic interactions during sexual competition elevate the risk of contracting cancers (as observed in Tasmanian devils). More generally, the functional relationships linking the allocation of resources to growth and reproduction might ensue increased DNA damages that can either directly or indirectly (via higher rate of immunosenescence) augment the risk of carcinogenesis. Taken together, this suggests that cancer risk worsens with chronological age with evidence that both reproductive allocation and cancer defence mechanisms are energetically costly, strongly highlight that the development of some cancers might be seen as a long-term reproductive cost . The picture might be even more complex, at least in females, where an absence or a very low rate of reproduction might itself increase the risk of developing cancers of the reproductive system (Pesavento, Agnew, Keel, & Woolard, 2018) . Basically, females that do not reproduce will experience a higher number of oestrous cycles and thus a greater exposure to oestrogen, which can ultimately lead to higher risk of cancers, as observed in humans (Britt & Short, 2012) and captive mammals (Pesavento et al., 2018) .
Although the fine-scale quantifications of cancer prevalence in the wild remain challenging (Madsen et al., 2017) , theoretical predictions and the availability of long-term physiological and demographic data on free-ranging populations now provide parts of the necessary material for studying the relationship between both reproductive and actuarial senescence and cancer in the light of early-and late life trade-offs. In addition, such datasets should also open up opportunities to investigate in depth the genetic and physiological bases of these processes. In the next section, we argue that among the physiological mechanisms underlying these relationships immunosenescence might play a critical role.
| DOE S C AN CER RE SULT FROM IMMUNOS ENE SCEN CE?
Immunosenescence involves the progressive morpho-functional involution of organs, as well as an age-related deterioration of cellular and humoral immune functions (Malaguarnera et al., 2001) . The atrophy of the thymus (the key organ for T-cell maturation) leads to decreased number of lymphoid precursor T cells and to the impairment of T-cell proliferative capacity with increasing age (see Malaguarnera et al., 2001 for a review). By acting as antibody-specific antigen presenting cells, T cells provide support to the development of antibody responses by B cells (i.e. T-cell-dependent B-cell activation; Parker, 1993) . CD4+ T cells provide helper signal to B cells to initiate their proliferation (Kurosaki, Kometani, & Ise, 2015) , and the lack of T cells can result in minimal memory B-cell development (Lafrenz & Feldbush, 1981) . Therefore, reduced functioning of T cells can limit the production of specific high-affinity antibodies potentially leading to a more restricted antibody repertoire (Rubelt et al., 2012; van Dijk-Härd, Söderström, Feld, Holmberg, & Lundkvist, 1997) . In parallel, with advancing age, the number of naïve lymphocytes and early progenitor B cells in the bone marrow also decreases, and the rate of B-cell maturation and generation decline (Allman & Miller, 2005; Linton & Dorshkind, 2004) . The decreased productions of T and B immune cells ultimately limit the efficiency of the adaptive immune system to cope with pathogens (Weksler, 2000) . In addition, while the efficiency of the humoral immune system's also generally declines with increasing age (Ujvari & Madsen, 2011; Weksler, 2000) , other arms of the immune system follow different age-specific trajectories. For example, the number of other key innate immune cells may actually increase with age or remain constant over the lifecourse (e.g. Cheynel et al., 2017 in two wild populations of roe deer, Capreolus capreolus). Overall, immunosenescence has now been documented in a wide range of species (e.g. Garschall & Flatt, 2018; Ujvari & Madsen, 2011) and is believed to strongly impair reproductive and survival prospects at late ages.
Because malignant cells are immunogenic, the immune system has the potential to recognize and to suppress carcinogenesis. In other words, the immune system not only plays a crucial role in recognizing, controlling and eliminating foreign pathogens, but also has the ability to recognize and remove malignant cells (Muenst et al., 2016) . Therefore, age-associated waning of immunity has been proposed to contribute to increased cancer incidence in older individuals (Pawelec, 2017;  see Figure 1 and Box 2 for further details on the mechanistic pathways involved). Moreover, the persistent antigenic stimulation caused by infection with pathogens (e.g. cytomegalovirus) throughout the lifetime of an organism may also generate an inflammatory environment favourable for tumour growth and also concurrently to direct resources from tumour surveillance to elimination of pathogens (Fulop et al., 2013; Mancuso et al., 2018; Box 2) . The dysfunction of immunity as the organism grows older will thus impair their ability to respond to diverse challenges, such as parasites and malignant cells.
The functional relationships linking immunosenescence and cancer emphasize that life-history and evolutionary theories of ageing can illuminate our understanding of carcinogenesis. Indeed, between-individual variation in immunosenescence patterns (and thus in cancer resistance) can thus be explained by differential allocation of resources towards costly biological functions such as growth or reproduction, in line with predictions of the disposable soma theory of ageing (Figure 1) . There is now a tremendous amount of evidence that maintaining baseline immunity or mounting an immune response is energetically costly (Lochmiller & Deerenberg, 2000) and might be impaired by increased allocation to growth or reproduction, as evidenced by experimental manipulations of brood size in birds (Demas, Greives, Chester, & French, 2012; Knowles, Nakagawa, & Sheldon, 2009 ). For instance, experimental increase in brood size in collared flycatcher (Ficedula albicolis) reduced their level of antibody response against Newcastle disease virus (Nordling, Andersson, Zohari, & Lars, 1998) . A decrease in immunocompetence following reproductive allocation has also been observed in European rabbits (Oryctolagus cuniculus) where both neutrophils and lymphocytes counts were lower in females that allocated heavily to reproduction (Rödel, Zapka, Stefanski, & Holst, 2016) . Moreover, several phylogenetic comparative studies have highlighted that immunocompetence is superior in species exhibiting slow pace of life (Pap et al., 2015; Tella, Scheuerlein, & Ricklefs, 2002) , indicating that an efficient immune system is a key to a long life. Further studies that investigate the association between lifehistory strategies and immunosenescence, not only from the classical host-parasite spectrum, but also by considering malignant cells (i.e. the oncobiota) as selective force (Russell et al., 2018; , are thus urgently needed.
| FROM MOSAI C AG EING TO A SYN CHRONI CIT Y OF AG E-S PECIFIC C ANCER INCIDENCE
Predictions from early evolutionary studies suggest that senescence should be a highly synchronized process among phenotypic traits or biological functions (Maynard Smith, 1962; Williams, 1957) .
However, increasing amount of evidence shows that age-specific patterns of senescence might be asynchronous between and among physiological and demographic traits Hayward et al., 2015) . In line with this observation, age-and sitespecific cancer incidences are exemplary of such asynchronicity.
Despite extensive research over the last 50 years, it remains unclear why certain tissues are significantly more vulnerable than others to developing or hosting malignancies. While Tomasetti and Vogelstein (2015) suggested that two-thirds of cancer types can be explained by tissue-specific stem cell division rates, Wu, Powers, Zhu, and Hannun (2016) rather proposed that cancer risk is heavily influenced by environmental factors. More recently, Thomas et al. (2016) suggested an alternative explanation based on the evolutionary ecology of organs that could explain why some neoplasms develop into lethal tumours while others remain benign for decades. This approach considers that the ecological conditions that characterize each organ, along with the way natural selection has optimized organs to maximize the individual's fitness, contribute to explaining the spatial and temporal patterns of cancer occurrences in the body. Furthermore, through time, cellular and tissue senescence may alter differently the various ecological parameters inside the organs as well as the efficiency of their natural defences against cancer. Mosaic ageing (sensu Walker & Herndon, 2010) , the heterogenous and idiosyncratic pattern of age on different cells, organs and system, therefore could also be extended to cancer.
In complex multicellular organisms, organs correspond to ecosystems with their own distinct ecologies (Thomas et al., 2016) . For instance, organs are characterized by particular structures, functions, abiotic (e.g. glucose, oxygen gradients, temperature, pH) and biotic conditions (microbial community), the extent of carrying capacity and spatial distribution of resources, the dimensions of networks with other organs, and last but not least, by the expanse of contact with the external world. Furthermore, organs differ in the way they relate to fitness, some being more essential than others for keeping the organism alive and reproduce efficiently (Thomas et al., 2016) . For instance, vital organs such as the heart, brain and pancreas are essential for survival, while others, such as the gallbladder and spleen, are not. In addition, organs found in pairs (lungs or kidneys) can still function even if only one is damaged. The assumption BOX 2 An overview of the mechanistic pathway linking immunosenescence and cancer
The first line of defence against both intrinsic and extrinsic challenges is generated by the innate immune system that is able to recognize pathogen-associated molecular patterns (PAMP) conserved among microbes as well as damage-associated molecular patterns (DAMP) generated by damaged cells and tissues (Muenst et al., 2016) . The innate immune system produces a fast and low-cost response that ultimately initiates an adaptive immune response during infection and tissue damage/inflammation (Liu & Zeng, 2012) .
The first immune effector cells from the innate response that directly target cancer cells include natural killer cells (NK), dendritic cells (DC), macrophages, polymorphonuclear leucocytes (PMN, such as neutrophils, eosinophils and basophils), mast cells and cytotoxic T lymphocytes (Liu & Zeng, 2012) . Direct molecular interactions between innate immune cells and cancer have been demonstrated in numerous studies. For example, NK cells kill non-MHC (major histocompatibility complex) expressing cancer cells by producing cytotoxic proteins (i.e. perforin and granzyme) that initiate the apoptosis of cancer cells. NK cells produce stimulatory receptors (e.g. natural killer group 2D), on their cell surface that attaches to ligands on the cancer cell surface and the binding stimulates NK cells to secrete inflammatory cytokines, and induce the death of cancer cells (Yokoyama & Plougastel, 2003) . PMN leucocytes and mast cells interact with antibody coated antigens on tumour cells and induce the release of cytokines and chemo-attractants that will recruit DC and macrophages to the cancer cells (Amulic, Cazalet, Hayes, Metzler, & Zychlinsky, 2012; Anisimov et al., 2005; Gregory & Houghton, 2011) .
DC and macrophages recognize the so called 'eat me' signals on apoptotic cells through specific receptors and eliminate the malignant cells by phagocytizing them (reviewed in Liu & Zeng, 2012) .
Natural killer T cells (NKT) and
DCs also create a bridge between innate and adaptive immune systems by secreting cytokines and chemokines, and stimulate T-and B-cell responses to cancer cells (Palucka, Banchereau, & Mellman, 2010) . Tumour-associated antigens (TAAs), originating from the large genetic alterations of tumours, are presented via the MHC on the tumour surface and trigger T-cell responses. Secretion of chemokines and cytokines leads to expansion of T cells, and ultimately, the malignant cells are destroyed by either cell-mediated or by indirect antibody complement-mediated cytotoxicity (Spurrell & Lockley, 2014) . TAA-specific adaptive immune responses can be generated by various subsets of T cells such as CD4+ T cells modulating the efficiency of the immune reaction and CD8+ T cells directly destroying TAA expressing cancer cells (Reuschenbach, von Knebel Doeberitz, & Wentzensen, 2009 ).
Overall, the involution of thymus with advancing age, the production of naïve immune cells (T cells) ceases, reserves of naïve cells become depleted, and susceptibility not only to previously un-encountered pathogens but also to antigens expressed by newly arising cancers can increase (Fulop et al., 2013; Pawelec, Derhovanessian, & Larbi, 2010) . that organs are perfect by design and intended to maximize health and life span is a common misconception in medicine (Brüne & Hochberg, 2013) . The evolutionary perspective (Nesse & Williams, 1996) emphasizes that trade-offs and constraints limit the perfection of every organ, and that selection maximizes reproductive success at the expense of health and life span. This implies that organs less crucial for survival and reproduction should be more vulnerable to pathologies (Thomas et al., 2016) . Alternatively, the strong selection for efficient reproduction that operates on reproductive organs, possibly associated with a higher expression of genes with antagonistic effects (see Section 2), might explain why, once standardized for organ mass, prostate and ovaries show the highest rates of cancer incidence in humans (Silva et al., 2011) .
These concepts are fundamental to understand organ-and agespecific incidences and prevalence of cancer in different organs. Akin to microbes, cancer cells depend on their tissue environment for sustenance and proliferation. The local ecological conditions in organs should therefore substantially influence cancer dynamics. In accordance with this idea, it is increasingly recognized that tumour development, progression and metastasis are strongly dependent on the microenvironmental conditions experienced by cancer cells (Bissell & Hines, 2011) . Interactions such as competition, mutualism and antagonism are likely to shape the somatic evolution of cancer cells (Crespi & Summers, 2005; Marusyk & Polyak, 2010) . Deterioration of organs with age may also favour malignant proliferation. Reduced cell proliferation and increased cell death with ageing display substantial variations among organs, as illustrated by Richardson, Allan, and Le (2014) . These authors showed that the loss of functional mass in tissues with ageing, which is related to the mitotic rate or rates of tissue turnover, is organ specific. With ageing, highly proliferative tissues also exhibit greater telomere erosion and hence replicative senescence (Ishii et al., 2006) . In young persons, tissue maintenance involves the removal of old and/or damaged cells, followed by their replacement by stem cells providing progenitors. Conversely, in the elderly, the most proliferative tissues display a lack of homeostasis and lose functional mass due to mutations of TP53, a mechanism/ process that is also frequently involved in the age-related rise of cancer incidences (Richardson et al., 2014) .
The adaptive theory proposed by DeGregori (2018) also provides an interesting conceptual framework to understand why the general of process of senescence can locally promote cells carrying malignant mutations and hence cancer. In this theory, tissues and organs are equivalent to adaptive landscapes, and healthy cells are best adapted to live in healthy young tissue. However, age-specific decline in tissue and organ structures or functions alters the adaptive landscapes, so that cells with oncogenic mutations may suddenly find themselves better adapted to their surroundings and hence may be able to out-compete healthy cells. Thus, while oncogenic mutations may always be present and/or accumulate through time, it is the state of the tissue environment that becomes the key determinant that either favours or disfavours cancer development.
For instance, introduction of oncogenes into old bone marrow progenitors in an old bone marrow environment in mice often leads to clonal expansion and leukaemia. Conversely, this is not observed when oncogenes are introduced into young bone marrow progenitors in a young bone marrow environment in mice (Henry et al., 2015) . Therefore, the age-related decline in tissues and organs (e.g. Liu et al., 2019 for a case study on skin senescence) promotes selection for new cellular phenotypes adapted to the new microenvironment. Interestingly, alteration in cellular niches due to ageing seems to be specific compared to other causes. For instance, lung cancers in the elderly and in smokers rely on different mutations (on EGFR and KRAS, respectively), while it is not expected that carcinogens from smoking induce KRAS mutations only (DeGregori, 2018) .
To conclude, eco-evolutionary approaches offer promising frameworks to investigate variations in cancer risk between organs and tissues. However, to go further, one would need to extend the classical evolutionary theory of ageing that aggregates all causes of death at the organism level and predict synchronization of senescence of physiological functions (Maynard Smith, 1962; Williams, 1957) to a model which encompasses the potential asynchronicity of senescence and trade-offs between physiological functions and anatomical sites.
| DYNAMI C INTERPL AY AND TR ADE-OFF B E T WEEN S ENE SCEN CE AND C AN CER
Because age is the strongest predictor of metastatic cancer development, it is usually assumed that cancer is a pathology of old ages (Frank, 2004; Rozhok & DeGregori, 2016) . This correlation may indeed involve causal processes, when for instance advancing age predisposes cells to accumulate oncogenic mutations, alters tissue microenvironments in a way that favours cells carrying oncogenic mutations (Section 43) and/or alter the efficiency of the mechanisms that normally hold in situ tumours in check (Section 32 and Box 2).
However, malignant pathologies also display a range of characteristics, suggesting that the occurrence of cancer might not automatically be a consequence of senescence .
Although the accumulation of numerous oncogenic manifestations (e.g. precancerous lesions and in situ carcinoma) throughout the life (being therefore highly prevalent before individuals are old, e.g. Bissell & Hines, 2011) might be seen as a direct expression of cellular, tissues or organs senescence, it might be only indirectly linked to the decline in fitness with age. Indeed, assuming that natural defences against malignant progression are associated with trade-offs for the host , one must also admit that oncogenic processes can be a cause, rather than a consequence of senescence. For instance, even when a cancer is apparently not invasive, we cannot exclude that it is energetically costly to keep such a cancer sub-lethal (Vittecoq et al., 2013) . Under the current evolutionary theories of ageing, the amount of resources devoted to limit malignant progression should, everything else being equal, impair somatic maintenance (e.g. the efficiency of the immune system) and ultimately lead to a much more pronounced reproductive and actuarial senescence. For instance, Arnal et al. (2017) found that females in Drosophila flies harbouring early stages of a gut cancer lay their eggs earlier than healthy females prior to their concomitantly earlier death . Since early ages at first reproduction are often associated with long-term reproductive and survival costs in animals (Lemaître et al., 2015) , this example suggests that cancer development during early life might strengthen demographic senescence. Another illustration of cancer-induced alteration in lifehistory strategies involves the Tasmanian devil and their aforementioned transmissible facial tumour disease. Basically, Tasmanian devil populations have responded to the cancer-induced mortality by transitioning from an iteroparous (multiple reproductive cycles) to a semelparous (single breeding at 1 year of age) reproduction (Jones, Cockburn, et al., 2008) .
Using an eco-evolutionary perspective to investigate how different hosts (with different life-history strategies) manage non-invasive (sub-lethal) malignant cells should help to understand the dynamic relationship linking cancer and senescence. More generally, it is important to adopt a novel view of malignant pathologies and recognize not only invasive/metastatic cancers as selective force, but rather to consider the entire oncobiota .
Oncogenic phenomena, taken in their totality, may indeed influence various aspects of individual fitness and thus modulate the numerous trade-offs occurring at the individual level (Stearns, 1992) , long before negative impacts on age-specific survival and reproductive probabilities become apparent . Embracing this view will be particularly relevant to understand how the great majority of cancers occurs late in life even if common malignancies in youth can still impair fitness on the long-run.
Finally, the causal link between oncogenic processes and senescence may also be mediated by trade-offs resulting from our constitutive defences against cancer as for instance trade-off between morbidity by cancers and other senescence-related causes of death. One possible mechanism mediating such trade-off could stem from the senescent-cell's theory of ageing (Van Deursen, 2014) . Senescent cells are stem/progenitor cells that stop replication and cease participating in tissue functioning and accumulate in tissues with age. Senescent state is seen as a mean to divert a cell potentially at risk of carcinogenesis to a 'safe' state where, avoiding replication, it is not a risk of accumulating further mutations.
Hence, the genes controlling for the entrance into the senescent state are mainly tumour suppressor genes. However, this has a cost: increased proportion of senescent cells compromises tissue renewing, functioning and therefore the organism's survival (Baker et al., 2016) . Thus, molecular and cellular theories predict a physiological trade-off between mortality components (dying from cancer or from other causes) mediated by the proportion of senescent cells (Finkel, Serrano, & Blasco, 2007) . For instance, apart from its wellknown cancer-suppressive function, activation of TP53 also modulates (together with other alternative molecular pathways) cellular senescence and organismal ageing (Rufini, Tucci, Celardo, & Melino, 2013) , leading to reduced tissue renewal and repair, stem cell deletion and organismal ageing through an antagonistic pleiotropy effect (Campisi, 2003; García-Cao et al., 2002) . Accordingly, mutated mice with a phenotypic effect analogous to the up-regulation of the TP53 gene have a reduced risk of cancer but in return display earlier onset of tissue atrophy and shortened life span (Donehower, 2002; Tyner et al., 2002) .
Over evolutionary time, selection might also have favoured compensatory adaptations, as illustrated by elephants (Loxodonta africana) that are long-lived mammals with a high number of copies of the TP53 gene coding p53 proteins (Abegglen et al., 2015) . Although the relatively low number of vertebrates at the same position as elephants along the slow-fast life-history trait continuum makes it difficult to draw general conclusions, slow species (e.g. long-lived birds) generally show limited functional and actuarial senescence (Jones, Gaillard, et al., 2008) . These examples clearly suggest that focusing on non-classical model organisms offers exciting opportunities to decipher the intimate relationship linking senescence and cancer, from the molecular to the whole-organism level. Overall, further studies are needed to determine the extent to which inter-individual variability in the vulnerability to carcinogenesis (due to strictly intrinsic or environmentally driven factors) correlates with differential senescence rates.
| CON CLUS IONS
Our perspective article highlights that the study of the relationship between senescence and cancer is still in its infancy. More specifically, we emphasize that the current evolutionary theories proposed to explain the evolution of senescence provide a solid background to better understand both cancer prevalence (e.g. if strong allocation to growth and reproduction facilitate cancer development) and timing (e.g. if the asynchrony in senescence patterns parallels the age-specific patterns of cancer development across organs). At the same time, we demonstrate that cancer might itself promote senescence or can even be embedded in a trade-off with senescence. Whether the directionality of the relationship between senescence and cancer varies among individuals, populations or species is currently unknown. However, we argue that research programmes aiming to embrace this question are particularly timely since modifications of the environmental conditions (especially significant perturbations caused by human activities) have been associated with increased cancer rates in wild populations. Although we are currently only scratching the surface of the potential importance of oncobiota in wild populations living in human-impacted habitats (Giraudeau, Sepp, Ujvari, Ewald, & Thomas, 2018; Hochberg & Noble, 2017; Pesavento et al., 2018; Vittecoq et al., 2018) , cancer in wildlife has also been suggested to be associated with other anthropogenic activities, such as nocturnal light pollution, intentional or accidental wildlife feeding, or reduction of genetic diversity in human-impacted habitats Sepp, Ujvari, Ewald, Thomas, & Giraudeau, 2019 et al., 2016) , possibly through the trade-off between reproduction and somatic maintenance (Lemaître et al., 2015) , a greater understanding of the dynamic interplay between senescence and cancer will become a major question for diverse research areas such as population dynamics, conservation biology, epidemiology or public health.
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